跳至主要内容
临床试验/ACTRN12614000556640
ACTRN12614000556640已完成未知

A pilot study to determine the likelihood of parents/guardians enrolling their infant into a randomised controlled trial of asthma risk with paracetamol versus ibuprofen use until the age of three at which time they will be assessed for wheeze and atopy.

Medical Research Institute of New Zealand0 个研究点目标入组 150 人开始时间: 2014年5月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
o limit 至 6 Weeks(—)
性别
All

入选标准

  • 1. Pregnant mothers attending ante-natal classes at Wellington Regional Hospital over a three-week period – specific dates to be arranged
  • 2. Mothers / parents / guardians and infants on post-natal wards at Wellington Regional Hospital over a three week period – specific dates to be arranged
  • 3. Mothers / parents / guardians and infants attending immunisation and 6-week checks at primary health care providers over a three-week period – primary health care providers and specific dates to be arranged

排除标准

  • Unable to give informed consent for study

研究者

相似试验

PILOT study - Recruitment: for a randomised... | 临床试验